MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1

CUSIP: 590328AA8

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class
Debt / NOTE 4.500% 7/1
Market price (% of par)
134.35%
Total 13F principal
$109,690,000
Principal change
+$1,483,000
Total reported market value
$147,492,000
Number of holders
20
Value change
+$4,620,806
Number of buys
9
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 590328AA8?
CUSIP 590328AA8 identifies 590328AA8 - MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 as of Q2 2014

As of 30 Jun 2014, MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 was held by 20 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $109,690,000 in principal (par value) of the bond. The largest 10 bondholders included Citadel Advisors LLC, WOLVERINE ASSET MANAGEMENT LLC, ARISTEIA CAPITAL LLC, Polygon Management Ltd., UBS OCONNOR LLC, AVIVA PLC, LAZARD ASSET MANAGEMENT LLC, TANG CAPITAL MANAGEMENT LLC, JPMORGAN CHASE & CO, and PUTNAM INVESTMENTS LLC. This page lists 20 institutional bondholders reporting positions for the Q2 2014 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.